Answers are grounded in this paper and cite their sources.
Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women. (Funded by the Bill and Melinda Gates Foundation; Partners PrEP ClinicalTrials.gov number, NCT00557245.).
No takes yet. Share an insight, caveat, or question.
Baeten et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: